Chemoinformatics Taking Biology into Account: Proteochemometrics

Computational Approaches in Cheminformatics and Bioinformatics

Volumn , Issue , 2011, Pages 57-92

  Wikberg, Jarl E S ^a   Spjuth, Ola ^a   Eklund, Martin ^a   Lapins, Maris ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chemoinformatics, proteochemometrics; Proteochemometrics in drug lead; Proteochemometrics, QSAR target

Indexed keywords

EID: 84878209403     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118131411.ch3     Document Type: Chapter

References (76)

1. Imming, P.; Sinning, C.; Meyer, A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discov. 2006, 5, 821-834.
2. Ashburn, T. T.; Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 2004, 3, 673-683.
3. Prusis, P.; Mucenience, R.; Andersson, P.; Lundstedt, T.; Wikberg, J. E. S. A process for identifying the active site in a biological target. 1999. G.B. Patent 99273346.8.
4. Lapinsh, M.; Gutcaits, A.; Prusis, P.; Post, C.; Lundstedt, T.; Wikberg, J. E. S. Classification of G-protein coupled receptors by alignment independent extraction of principal chemical properties of primary amino acid sequences. Protein Sci . 2002, 11, 795-805.
5. Wikberg, J. E. S.; Lapinsh, M.; Prusis, P. Proteochemometrics: a tool for modelling the molecular interaction space. In Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, Kubinyi, H.; M̈uller, G., Eds. Wiley-VCH, Weinheim, Germany, 2004, pp. 289-309.
6. Freyhult, E.; Prusis, P.; Lapinsh, M.; Wikberg, J. E. S.; Moulton, V.; Gustafsson, M. G. Unbiased descriptor and parameter selection confirms the potential of proteochemometric modelling. BMC Bioinf . 2005, 6.
7. Prusis, P.; Uhlen, S.; Petrovska, R.; Lapinsh, M.; Wikberg, J. E. S. Prediction of indirect interactions in proteins. BMC Bioinf . 2006, 7, 167.
8. Str̈ombergsson, H.; Kryshtafovych, A.; Prusis, P.; Fidelis, K.; Wikberg, J. E. S.; Komorowski, J.; Hvidsten, T. R. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures. Proteins 2006, 65, 568-579.
9. Mandrika, I.; Prusis, P.; Yahorava, S.; Shikhagie, M.; Wikberg, J. E. S. Proteochemometric modelling of antibody-antigen interactions using SPOT synthesised peptide arrays. Protein Eng. Des. Sel. 2007, 20, 301-307.
10. Kontijevskis, A.; Prusis, P.; Petrovska, R.; Yahorava, S.; Mutulis, F.; Mutule, I.; Komorowski, J.; Wikberg, J. E. S. A look inside HIV resistance through retroviral protease interaction maps. PloS Comput. Biol. 2007, 3.
11. Wikberg, J. E. S.; Mutulis, F. Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction. Nat. Rev. Drug Discov. 2008, 7, 307-323.
12. Str̈ombergsson, H.; Daniluk, P.; Kryshtafovych, A.; Fidelis, K.; Wikberg, J. E. S.; Kleywegt, G. J.; Hvidsten, T. R. Interaction model based on local protein substructures generalizes to the entire structural enzyme-ligand space. J. Chem. Inf. Model. 2008, 48, 2278-2288.
13. Lapinsh, M.; Prusis, P.; Mutule, I.; Mutulis, F.; Wikberg, J. E. S. QSAR and proteochemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. J. Med. Chem. 2003, 46, 2572-2579.
14. Wold, S.; Sj̈ostr̈om, M.; Carlson, R.; Lundstedt, T.; Hellberg, S.; Skagerberg, B.; Wikström, C.; Öhman, J. Multivariate design. Anal. Chim. Acta 1986, 191, 17-32.
15. Cramer, R. D. R.; Patterson, D. E.; Bunce, J. D. Recent advances in comparative molecular field analysis (CoMFA). Prog. Clin. Biol. Res. 1989, 291, 161-165.
16. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4146.
17. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-857.
18. Pastor, M.; Cruciani, G.; McLay, I.; Pickett, S.; Clementi, S. Gridindependent descriptors (GRIND): a novel class of alignment-independent threedimensional molecular descriptors. J. Med. Chem. 2000, 43, 323-324.
19. Fontaine, F.; Pastor, M.; Sanz, F.; Incorporating molecular shape into the alignment-free grid-independent descriptors. J. Med. Chem. 2004, 47, 2805-2815.
20. Lapinsh, M.; Prusis, P.; Uhlen, S.; Wikberg, J. E. S. Improved approach for proteochemometrics modeling: application to organic compound-amine G protein-coupled receptor interactions. Bioinformatics 2005, 21, 4289-4296.
21. Vedani, A.; Dobler, M. 5D-QSAR: the key for simulating induced fit? J. Med. Chem. 2002, 45, 2139-2149.
22. Vedani, A.; Dobler, M.; Lill, M. A. Combining protein modeling and 6DQSAR: simulating the binding of structurally diverse ligands to the estrogen receptor. J. Med. Chem. 2005, 48, 3700-3703.
23. Hellberg, S.; Sj̈ostr̈om, M.; Skagerberg, B.; Wold, S. Peptide quantitative structure-activity relationships, a multivariate approach. J. Med. Chem. 1987, 30, 1126-1135.
24. Sandberg, M.; Eriksson, L.; Jonsson, J.; Sj̈ostr̈om, M.; Wold, S. New chemical descriptors relevant for the design of biologically active peptides: a multivariate characterization of 87 amino acids. J. Med. Chem. 1998, 41, 2481-2491.
25. Gottfries, J. The drug designer's guide to selectivity. J. Chemometr. Intell. Lab. 2006, 83, 148-156.
26. Muthas, D.; Lek, P. M.; Nurbo, J.; Karlen, A.; Lundstedt, T. Focused hierarchical design of peptide libraries-follow the lead. J. Chemometr. 2007, 21, 486-495.
27. Wold, S.; Jonsson, J.; Sj̈ostr̈om, M.; Sandberg, M.; R̈annar, S. DNA and peptide sequences and chemical processes multivariately modelled by principal component analysis and partial least-squares projections to latent structures. Anal. Chim. Acta 1993, 277, 239-253.
28. Benson, D. C. Fourier methods for biosequence analysis. Nucleic Acids Res. 1990, 18, 6305-6310.
29. Chou, K. C. Prediction of protein subcellular locations by incorporating quasi-sequence-order effect. Biochem. Biophys. Res. Commun. 2000, 278, 477-483.
30. Dubchak, I.; Muchnik, I.; Holbrook, S. R.; Kim, S. H. Prediction of protein folding class using global description of amino acid sequence. Proc. Natl. Acad. Sci. USA 1995, 92, 8700-8704.
31. Lapinsh, M.; Prusis, P.; Gutcaits, A.; Lundstedt, T.; Wikberg, J. E. S. Development of proteochemometrics: a novel technology of use for analysis of drug-receptor interactions. Biochem. Biophys. Acta 2001, 1525, 180-190.
32. Lapinsh, M.; Veiksina, S.; Uhlen, S.; Petrovska, R.; Mutule, I.; Mutulis, F.; Yahorava, S.; Prusis, P.; Wikberg, J. E. S. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes. Mol. Pharmacol. 2005, 67, 50-59.
33. Lapinsh, M.; Prusis, P.; Petrovska, R.; Uhlen, S.; Mutule, I.; Veiksina, S.; Wikberg, J. E. S. Proteochemometric modeling reveals the interaction site for Trp9 modified a-MSH peptides in melanocortin receptors. Proteins: Struct. Funct. Bioinf . 2007, 67, 653-660.
34. Kontijevskis, A.; Petrovska, R.; Mutule, I.; Uhlen, S.; Komorowski, J.; P., P.; Wikberg, J. E. S. Proteochemometric analysis of small cyclic peptides' interaction with wild-type and chimeric melanocortin receptors. Proteins 2007, 83-96.
35. Lapinsh, M.; Prusis, P.; Wikberg, J. E. S. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. Mol. Pharmacol. 2002, 61, 1465-1475.
36. Hvidsten, T. R.; Kryshtafovych, A.; Komorowski, J.; Fidelis, K. A novel approach to fold recognition using sequence-derived properties from sets of structurally similar local fragments of proteins. Bioinformatics 2003, 19 (Suppl. 2), ii81-ii91.
37. Lindstr̈om, A.; Pettersson, F.; Almqvist, F.; Berglund, A.; Kihlberg, J.; Linusson, A. Hierarchical PLS modeling for predicting the binding of a comprehensive set of structurally diverse protein-ligand complexes. J. Chem. Inf. Model. 2006, 46, 1154-1167.
38. Zhang, S.; Golbraikh, A.; Tropsha, A. Development of quantitative structurebinding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces. J. Med. Chem. 2006, 49, 2713-2724.
39. Lapins, M.; Eklund, M.; Spjuth, O.; Prusis, P.; Wikberg, J. E. S. Proteochemometric modeling of HIV protease susceptibility. BMC Bioinf . 2008, 9, 181.
40. HIV Drug Research Centre. http://hivdrc.org. Accessed Nov. 2008.
41. Kontijevskis, A.; Komorowski, J.; J. E. S.; W. Generalized proteochemometric model of multiple cytochrome P450 enzymes and their inhibitors. J. Chem. Inf. Model. 2008, 48, 1840-1850.
42. Prusis, P.; Lapins, M.; Yahorava, S.; Petrovska, R.; Niyomrattanakit, P.; Katzenmeier, G.; Wikberg, J. E. S. Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. Bioorg. Med. Chem. 2008, 16, 9369-9377.
43. Chen, J. R.; Chang, B. H.; Allen, J. E.; Stiffler, M. A.; MacBeath, G. Predicting PDZ domain-peptide interactions from primary sequences. Nat. Biotechnol. 2008, 26, 1041-1045.
44. Bock, J. R.; Gough, D. A. Virtual screen for ligands of orphan G proteincoupled receptors. J. Chem. Inf. Model. 2005, 45, 1402-1414.
45. Bock, J. R.; Gough, D. A. Predicting protein-protein interactions from primary structure. Bioinformatics 2001, 17, 455-460.
46. Bock, J. R.; Gough, D. A. Whole-proteome interaction mining. Bioinformatics 2003, 19, 125-134.
47. Chemical Computing Group. http://www.chemcomp.com. Accessed Nov. 2008.
48. Tripos. http://tripos.com. Accessed Nov. 2008.
49. Strand Life Sciences. http://www.strandls.com. Accessed Nov. 2008.
50. Accelrys Software. http://accelrys.com. Accessed Nov. 2008.
51. Talete. http://www.talete.mi.it. Accessed Nov. 2008.
52. MIA S.r.l. http://miasrl.com/. Accessed Nov. 2008.
53. Umetrics. http://www.umetrics.com/. Accessed Nov. 2008.
54. Camo. http://www.camo.com. Accessed Nov. 2008.
55. SPSS. http://spss.com/. Accessed Nov. 2008.
56. SAS. http://www.sas.com/. Accessed Nov. 2008.
57. Clamp, M.; Cuff, J.; Searle, S. M.; Barton, G. J. The Jalview Java alignment editor. Bioinformatics 2004, 20, 426-427.
58. JalView. http://www.jalview.org. Accessed Nov. 2008.
59. The R Project for Statistical Computing. http://www.r-project.org. Accessed Nov. 2008.
60. Spjuth, O.; Helmus, T.;Willighagen, E. L.; Kuhn, S.; Eklund, E.;Wagener, J.; Murray-Rust, P.; Steinbeck, C.; Wikberg, J. E. S. Bioclipse: an open source workbench for chemo- and bioinformatics. BMC Bioinf . 2007, 8, 59.
61. Bioclipse. http://www.bioclipse.net. Accessed Nov. 2008.
62. Neerincx, P. B.; Leunissen, J. A. Evolution ofWeb services in bioinformatics. Brief Bioinf . 2005, 6, 178-188.
63. Curcin, V.; Ghanem, M.; Guo, Y. Web services in the life sciences. Drug Discov. Today 2005, 10, 865-871.
64. Eclipse. http://www.eclipse.org. Accessed Nov. 2008.
65. Genetta Soft. http://www.genettasoft.com. Accessed Nov. 2008.
66. Zimmermann, G. R.; Lehar, J.; Keith, C. T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today. 2007, 12, 34-42.
67. Murray-Rust, P. Chemistry for everyone. Nature 2008, 451, 648-651.
68. Web 2.0. http://en.wikipedia.org/wiki/Web2. Accessed Nov. 2008.
69. HUPO. http://www.hupo.org/. Accessed Nov. 2008.
70. MGED Society. http://www.mged.org/. Accessed Nov. 2008.
71. NIMH Psychoactive Drug Screening Program. http://pdsp.med.unc.edu. Accessed Nov. 2008.
72. EMBL-EBI, Swiss-Prot. http://www.ebi.ac.uk/swissprot/. Accessed Nov. 2008.
73. Baldwin, J. M.; Schertler, G. F.; Unger, V. M. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 1997, 272, 144-164.
74. Perl. http://www.perl.org/. Accessed Nov. 2008.
75. Symyx MDL. http://www.mdli.com/. Accessed Nov. 2008.
76. Wikberg, J. E. S.; Eklund, M.; Willighagen, E. L.; Spjuth, O.; Lapins, M.; Engkrist, O.; Aluarsson, J.; Introduction to Pharmaceutical bioinformatics, 2011 bakleaf, Stockholm ISBN 978-91-979403-0-6.